
Sign up to save your podcasts
Or


Ian Pavord (Thorax editor) talks to Peter Gibson (professor of respiratory medicine, John Hunter Hospital, New South Wales, Australia) about non-eosinophilic asthma, particularly neutrophilic asthma.
They discuss the stability of the different inflammatory phenotypes, tools to recognise non-eosinophilic asthma, whether these patients benefit from inhaled steroids, and Professor Gibson’s paper investigating the relationship between H influenzae respiratory infection and neutrophilic asthma.
See also:
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma
By BMJ Group4
11 ratings
Ian Pavord (Thorax editor) talks to Peter Gibson (professor of respiratory medicine, John Hunter Hospital, New South Wales, Australia) about non-eosinophilic asthma, particularly neutrophilic asthma.
They discuss the stability of the different inflammatory phenotypes, tools to recognise non-eosinophilic asthma, whether these patients benefit from inhaled steroids, and Professor Gibson’s paper investigating the relationship between H influenzae respiratory infection and neutrophilic asthma.
See also:
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma

134 Listeners

321 Listeners

504 Listeners

40 Listeners

49 Listeners

5 Listeners

9 Listeners

7 Listeners

4 Listeners

3 Listeners

7 Listeners

10 Listeners

41 Listeners

14 Listeners

1 Listeners

53 Listeners

0 Listeners

6 Listeners

906 Listeners

15 Listeners

3 Listeners

3 Listeners

26 Listeners

1,150 Listeners

194 Listeners

23 Listeners

367 Listeners

437 Listeners

2,131 Listeners

270 Listeners

0 Listeners